Heading Health, an Austin, TX-based insurance-based mental healthcare provider, raised $4.5M in Series A funding.
The round was led by Gron Ventures and Jam Fund, with participation from the One Mind Accelerator, Thiel Capital, Mystic Ventures, Gaingels, and Antifund.
The company intends to use the funds to scale into new markets and invest in its care delivery and analytics platform.
Founded in 2020 by Co-founder Steve Levine, MD and CEO, Simon Tankel, Heading is a mental health company that combines evidence-based practices, personalized treatment plans. Today it offers a continuum of in-network mental health services for hard to treat conditions including interventional psychiatric services like intramuscular ketamine, Spravato, and TMS in their centers, along with psychiatry and therapy conveniently available through telehealth.
Heading has locations in the Austin and Dallas-Forth Worth metros, with plans for further expansion in Dallas and a first location in Houston later this year.
